Down-regulation of proteolytic complexes following EBV activation in BL cells.

[1]  E. Kieff,et al.  Virus and Cell RNAs Expressed during Epstein-Barr Virus Replication , 2006, Journal of Virology.

[2]  Seongman Kang,et al.  E3 ubiquitin ligase RNF2 interacts with the S6' proteasomal ATPase subunit and increases the ATP hydrolysis activity of S6'. , 2005, The Biochemical journal.

[3]  M. Bogyo,et al.  Pathways Accessory to Proteasomal Proteolysis Are Less Efficient in Major Histocompatibility Complex Class I Antigen Production* , 2003, The Journal of Biological Chemistry.

[4]  M. Masucci,et al.  The ubiquitin/proteasome system in Epstein-Barr virus latency and associated malignancies. , 2003, Seminars in cancer biology.

[5]  K. Früh,et al.  Immune evasion by a novel family of viral PHD/LAP-finger proteins of gamma-2 herpesviruses and poxviruses. , 2002, Virus research.

[6]  H. Ploegh,et al.  Kaposi's Sarcoma-Associated Herpesvirus K3 Utilizes the Ubiquitin-Proteasome System in Routing Class I Major Histocompatibility Complexes to Late Endocytic Compartments , 2002, Journal of Virology.

[7]  A. Rickinson.  Epstein-Barr virus. , 2001, Virus research.

[8]  D. Thorley-Lawson,et al.  Epstein-Barr virus: exploiting the immune system , 2001, Nature Reviews Immunology.

[9]  R. Longnecker,et al.  Epstein-Barr Virus Latent Membrane Protein 2a (Lmp2a) Employs the Slp-65 Signaling Module , 2001, The Journal of experimental medicine.

[10]  K. Brown,et al.  Differential Signaling and Tumor Necrosis Factor Receptor–Associated Factor (Traf) Degradation Mediated by Cd40 and the Epstein-Barr Virus Oncoprotein Latent Membrane Protein 1 (Lmp1) , 2001, The Journal of experimental medicine.

[11]  M. Masucci,et al.  c-myc overexpression activates alternative pathways for intracellular proteolysis in lymphoma cells , 2001, Nature Cell Biology.

[12]  Tony Pawson,et al.  Latent Membrane Protein 2A of Epstein-Barr Virus Binds WW Domain E3 Protein-Ubiquitin Ligases That Ubiquitinate B-Cell Tyrosine Kinases , 2000, Molecular and Cellular Biology.

[13]  Alexander Varshavsky,et al.  The ubiquitin system. , 1998, Annual review of biochemistry.

[14]  M. Bogyo,et al.  Integration of the ubiquitin-proteasome pathway with a cytosolic oligopeptidase activity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[15]  E. Bloemena,et al.  Direct Immunosuppressive Effects of EBV-Encoded Latent Membrane Protein 1 , 2000, The Journal of Immunology.

[16]  R. Longnecker,et al.  The Epstein-Barr virus latent membrane protein 2A PY motif recruits WW domain-containing ubiquitin-protein ligases. , 2000, Virology.

[17]  P. Kloetzel,et al.  Efficient Generation of a Hepatitis B Virus Cytotoxic T Lymphocyte Epitope Requires the Structural Features of Immunoproteasomes , 2000, The Journal of experimental medicine.

[18]  M. Ceridono,et al.  Interactions of Epstein-Barr virus origins of replication with nuclear matrix in the latent and in the lytic phases of viral infection. , 1999, Virology.

[19]  W. Baumeister,et al.  A giant protease with potential to substitute for some functions of the proteasome. , 1999, Science.

[20]  Robert Huber,et al.  Contribution of Proteasomal β-Subunits to the Cleavage of Peptide Substrates Analyzed with Yeast Mutants* , 1998, The Journal of Biological Chemistry.

[21]  M. Kasahara,et al.  The MHC class I ligand‐generating system: roles of immunoproteasomes and the interferon‐4gMY‐inducible proteasome activator PA28 , 1998, Immunological reviews.

[22]  M. Bogyo,et al.  A proteolytic system that compensates for loss of proteasome function , 1998, Nature.

[23]  T. Chatila,et al.  Reactivation of Epstein-Barr virus: regulation and function of the BZLF1 gene. , 1997, Trends in microbiology.

[24]  Stefan Imreh,et al.  Inhibition of antigen processing by the internal repeat region of the Epstein–Barr virus nuclear antigen-1 , 1995, Nature.

[25]  A. Goldberg,et al.  Gamma-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes. , 1993, Nature.

[26]  K. Takada,et al.  Synchronous and sequential activation of latently infected Epstein-Barr virus genomes , 1989, Journal of virology.

[27]  O. Zetterqvist,et al.  Purification, substrate specificity, and classification of tripeptidyl peptidase II. , 1986, The Journal of biological chemistry.

[28]  A. Polack,et al.  Two deletions in the Epstein-Barr virus genome of the Burkitt lymphoma nonproducer line Raji. , 1984, Virology.

[29]  E. Kieff.  Epstein-Barr virus and its replication , 1996 .

[30]  W. Baumeister,et al.  Structural features of 26S and 20S proteasomes. , 1993, Enzyme & protein.